Clinical trial
A Prospective, Open Label, Single Arm Study to Evaluation the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Elderly Patients With Hypertension
NCT00412932 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open Label, Single Arm Study to Evaluation the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Elderly Patients With Hypertension
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2006
- Completion date
- April 30, 2008
- Enrollment
- 178 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.